AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

AcelRx Pharmaceuticals names Kim Gaumer as VP, Regulatory Affairs and Quality Assurance.

Europe Intelligence Wire

| April 18, 2012 | COPYRIGHT 2003 Financial Times Ltd. (Hide copyright information)Copyright

(From Pharma)

M2PHARMA-April 18, 2012-AcelRx Pharmaceuticals names Kim Gaumer as VP, Regulatory Affairs and Quality Assurance (C)2012 M2 COMMUNICATIONS http://www.m2.com

AcelRx Pharmaceuticals Inc (ACRX), a specialIty pharmaceutical company, announced on Tuesday the appointment of Kimberley Gaumer as vice president, Regulatory Affairs and Quality Assurance.

In her new role, Gaumer will lead all global regulatory, quality and compliance activities for AcelRx, including the development and prosecution of regulatory filings for ARX-01, the Sufentanil NanoTab PCA System, currently in Phase 3 clinical trials.

In addition, she will manage regulatory …

Related articles from newspapers, magazines, journals, and more
Array BioPharma Inc elects Dr. Howard Holden as vice president of Regulatory...
News wire article from: Europe Intelligence Wire April 19, 2012 700+ words
Galectin Therapeutics Inc Names Rex Horton as Executive Director of...
News wire article from: Europe Intelligence Wire January 16, 2013 700+ words
Insulet Corporation Names Tracey H Wielinski as VP, Global...
News wire article from: Europe Intelligence Wire January 24, 2013 700+ words
For GLPs, quality unit can be extension of FDA or means to help lab staff, or...
Newspaper article from: Bioresearch Monitoring Alert Ludwig, Elisa May 1, 2003 700+ words
Clinimetrics announces corporate expansion.
News wire article from: Asia Africa Intelligence Wire April 28, 2003 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily